A New Era in Healthcare: Çetin Ay and Prof. Mike Chan Bridge Continents through Medical Innovation

Technology, Trust, and Knowledge Flow Into Türkiye:  Prof. Dato’ Sri Dr. Mike Chan, Chairman of BWA Malaysia, and Çetin Ay, President of BWA Turkey, seal a landmark partnership to advance bioregenerative medicine and wellness from Germany to Türkiye—uniting science, innovation, and international trust.

From Europe to Asia, a groundbreaking partnership is taking shape in Türkiye—where science, capital, and a human-centered vision converge.

World-renowned biomedical scientist Prof. Dato’ Sri Dr. Mike Chan recently introduced the Human Cytology Atlas—a revolutionary classification of over 400 distinct brain, organ, and body cell types—that is reshaping global approaches to regenerative medicine. At the core of this movement lies a strategic alliance with international business leader and BWA Türkiye President Çetin Ay, who is bringing this vision to life in Türkiye.

Çetin Ay’s Leadership: Where Medicine Meets Strategic Investment

For Çetin Ay, medical innovation is not merely a healthcare initiative—it’s a national development imperative and a long-term investment in human capital. By partnering with European scientific excellence and integrating it into Türkiye’s advanced medical infrastructure, Ay is positioning the country as a future epicenter for bioregenerative medicine and wellness.

Çetin Ay was officially appointed as the President of the Federal Association for Economic Development and Foreign Trade (BWA) in Türkiye in 2021. In this role, he has been instrumental in fostering bilateral economic and scientific cooperation between Türkiye and Europe.

More than just a financial backer, Çetin Ay is recognized as a visionary implementer, trusted across Europe, Asia, and the Gulf.

“Those who invest in biotechnology today will build the healthy societies and resilient economies of tomorrow.”
— Çetin Ay, International Businessman & BWA Türkiye President

A Commitment to Human Dignity

This initiative, supported by high-level dialogues with Türkiye’s Ministry of Health, will be anchored in a state-of-the-art medical complex, already built and ready for deployment. What sets the project apart is its bold shift from conventional hospital models to a personalized, organ-specific therapeutic system rooted in cutting-edge science.

As Prof. Chan emphasizes, the partnership is not just about healing, but about turning scientific insight into human impact.

“Every human cell is a key. A treatment that does not match the cell will never unlock healing. In Türkiye, we are decoding that lock.” — Prof. Dato’ Sri Dr. Mike Chan, Biomedical Visionary & Scientist

From Recipient to Producer: Türkiye Rises as a Health Innovation Hub

This model empowers Türkiye not only as a treatment destination but as a producer of medical knowledge and biomedical technology. Thanks to Ay’s international network, a wide spectrum of investors, scientists, and patients from Europe, the Gulf, and Asia are now being directed toward Türkiye.

Global Precision, Local Trust: A New Paradigm With Çetin Ay and BWA: Global Precision, Local Trust

Çetin Ay is not merely establishing a medical facility—he is building Türkiye’s global credibility in the biomedical space. This initiative marks the beginning of a new health diplomacy, where Türkiye stands as a trusted destination for high-impact, future-focused medical investment.

The partnership represents a bold new direction in medical science—bridging continents, elevating care, and empowering humanity.